
We look forward to meeting you!
Visit us at the American Diabetes Association's 82nd Scientific Sessions at booth #1027 and hear from our experts during a special presentations.
On this page, you will find the most up-to-date schedule of our clinical program, along with the schedule for our in-booth presentations.
Dexcom product theater*
You're invited to join us for a product theater presentation about the latest clinical breakthroughs and outcomes from Dexcom, a leader in real-time continuous glucose monitoring (RT-CGM) during the conference.
Know more, see more, and do more with dexcom cgm
Sunday, June 5, 2022 | 3:00-3:45 pm (CST) | Product Theater #1
We are excited to see you at our booth and would like to invite you to our clinical session. This program will highlight ways to optimize CGM for people with type 1 or type 2 diabetes, as well as the unique features of Dexcom CGM that have been shown to help patients improve glycemic control and reduce the burden of diabetes care. Additionally, our experts will share their practical experience to help you gain confidence and improve the efficiency and effectiveness of clinical decision-making using CGM.
Dexcom in-booth presentations
We will be offering 15-minute in-booth presentations highlighting our Dexcom CGM product portfolio. These sessions will be led by members of the Dexcom clinical and medical education teams and will provide an overview of key benefits and features. Meet us at booth #1027 to learn more.
Saturday, June 4
11:45 am–12:00 pm
1:00–1:15 pm
2:00–2:15 pm
3:00–3:15 pm
Sunday, june 5
10:30–10:45 am
11:45 am–12:00 pm
1:00–1:15 pm
1:45–2:00 pm
Monday, June 6
11:15–11:30 am
1:15–1:30 pm
1:45–2:00 pm
*This program is not part of American Diabetes Association’s 82nd Scientific Sessions as planned by the American Diabetes Association.
This event is neither sponsored nor endorsed by the American Diabetes Association. This event does not qualify for continuing medical education (CME) credit.
Dexcom is a trademark or a registered trademark of Dexcom, Inc. in the U.S., and may be in other countries. LBL-1000936 REV001